Xinming Xie
Lanzhou University of Technology(CN)First Affiliated Hospital of Xi'an Jiaotong University(CN)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Cancer-related molecular mechanisms research, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → ERK/Drp1‐dependent mitochondrial fission contributes to HMGB1‐induced autophagy in pulmonary arterial hypertension(2021)131 cited
- → Activation of AMPK inhibits TGF-β1-induced airway smooth muscle cells proliferation and its potential mechanisms(2018)55 cited
- → Activation of PPARγ attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels(2014)53 cited
- → An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development(2021)51 cited
- → Activation of AMPK attenuates LPS-induced acute lung injury by upregulation of PGC1α and SOD1(2016)48 cited
- → The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma(2015)39 cited